Teladoc Health, Inc. TDOC
8.67 USD -0.28 (-3.08%)
Nov 12, 2026, 3:52 PM EST
8.66 Day range 8.71
4.40 52-week range 9.89
- YTD
- +23.79%
- 1 year
- +16.00%
News
businesswire.com Teladoc Health Canada Named Strategic Innovation Partner by NL Health Services to Advance Virtual Care Across the Province TORONTO--(BUSINESS WIRE)--Teladoc Health Canada has been named a Strategic Innovation Partner by Newfoundland and Labrador Health Services (NLHS), building on an established collaboration to create…
globenewswire.com A $400 Billion Healthcare Opportunity: Telehealth Companies Positioned to Capitalize on a Massive Industry Shift NEW YORK, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Healthcare is changing, and telehealth is becoming a bigger part of that shift. Patients want easier access to doctors, hospitals are looking for more…
benzinga.com TD Cowen Maintains Hold on Teladoc Health, Raises Price Target to $8 TD Cowen analyst Charles Rhyee maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $6 to $8.- benzinga.com Wells Fargo Maintains Equal-Weight on Teladoc Health, Raises Price Target to $8 Wells Fargo analyst Stan Berenshteyn maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $6 to $8.
benzinga.com Barclays Maintains Equal-Weight on Teladoc Health, Raises Price Target to $9 Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $7 to $9.
benzinga.com UBS Maintains Neutral on Teladoc Health, Raises Price Target to $9 UBS analyst Kevin Caliendo maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $6.5 to $9.
benzinga.com Oppenheimer Maintains Outperform on Teladoc Health, Raises Price Target to $10 Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $7 to $10.
benzinga.com JP Morgan Maintains Neutral on Teladoc Health, Raises Price Target to $10 JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $8 to $10.
benzinga.com Crude Oil Moves Lower; Caterpillar Shares Fall Following Q3 Results U.S. stocks fell Thursday, led by a 9% Caterpillar drop; Porch, Teladoc and Crocs surged, while oil, gold and silver declined.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc…
benzinga.com Huntington Ingalls, Crocs, Carvana, Insmed And Other Big Stocks Moving Higher On Thursday Stocks rallied on strong earnings and raised guidance, led by Huntington Ingalls, Porch, Teladoc and Crocs, despite the Dow falling 150 points.- benzinga.com Stifel Maintains Hold on Teladoc Health, Raises Price Target to $6.5 Stifel analyst David Grossman maintains Teladoc Health (NYSE:TDOC) with a Hold and raises the price target from $5.5 to $6.5.
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Mesoblast (NASDAQ:MESO) stock rose 16.2% to $15.57 during Thursday's pre-market session. The market value of their outstanding shares is at $1.7 billion. Glaukos (NYSE:GKOS) stock rose 15.75%…
benzinga.com Teladoc Stock Rallies After Double Beat; Lifts FY26 GAAP EPS Outlook Teladoc Health is rising Thursday after it reported better-than-expected Q3 results late Wednesday and raised its 2026 GAAP EPS guidance.
benzinga.com Teladoc Health Stock Rises After Q3 Double Beat Teladoc Health Inc (NYSE:TDOC) shares are rising in Wednesday's after-hours session after the company reports better-than-expected results for the third quarter.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 20.4% to $0.34 during Wednesday's after-market session. Glaukos (NYSE:GKOS) stock rose 16.85% to $212.01. The company's market cap stands at $10.6…
- benzinga.com Teladoc Health Q3 EPS $(0.15) Beats $(0.21) Estimate, Sales $605.102M Beat $588.477M Estimate Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.21) by 28.57 percent. This is a 46.43 percent increase over losses of…
benzinga.com Teladoc Health Sees Q4 GAAP EPS $(0.23)-$(0.03) vs $(0.11) Est; Sees Sales $569.000M-$615.000M vs $597.389M Est Teladoc Health (NYSE:TDOC) is looking for Q4 GAAP EPS of $(0.23)-$(0.03) vs $(0.11) analyst estimate. sees sales of $569.000 million-$615.000 million vs $597.389 million analyst estimate.- benzinga.com Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.362B-$2.447B to $2.395B-$2.441B vs $2.406B Est Teladoc Health (NYSE:TDOC) raises FY2026 GAAP EPS guidance from $(1.00)-$(0.75) to $(0.95)-$(0.75) vs $(0.89) analyst estimate. Narrows FY2026 sales outlook from $2.362 billion-$2.447 billion to…
benzinga.com Teladoc Turns Smartphone Cameras Into AI-Powered Vital Sign Monitors Teladoc Health adds AI tools SoloVitals and SoloScribe to its Solo platform to streamline hospital workflows and remote care.- benzinga.com Teladoc Health Adds Two New AI-Powered Capabilities To Its Enterprise Smart Care Platform Solo SoloVitals and SoloScribe are designed to help health systems bring timely patient insights into the care environment, while reducing technology fragmentation and helping care teams stay focused on…
- benzinga.com Teladoc Health Appoints Michael Grasher As CFO, Effective Immediately Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at delivering disciplined, sustainable growth NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Teladoc…
benzinga.com Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5 Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11 to $7.5.
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular session. GlucoTrack (NASDAQ:GCTK) shares moved upwards by 79.85% to $0.51. The company's market cap…- benzinga.com Canaccord Genuity Maintains Buy on Teladoc Health, Lowers Price Target to $10 Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lowers the price target from $11 to $10.
benzinga.com Evercore ISI Group Maintains In-Line on Teladoc Health, Lowers Price Target to $7.5 Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line and lowers the price target from $10 to $7.5.
benzinga.com Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlook Teladoc Health shares slid in Thursday's premarket after Q2 results and a cautious outlook tempered its earnings outlook.- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session. GlucoTrack (NASDAQ:GCTK) stock increased by 47.36% to $0.42. The market value of their outstanding…
benzinga.com Meta Posts Mixed Q2 Results, Joins Coursera, Qualcomm And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session U.S. stock futures rise, Meta shares drop 9.4%, Teladoc Health and Rentokil Initial fall after mixed financial results.
benzinga.com Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market session. Onconetix (NASDAQ:ONCO) shares moved upwards by 27.46% to $0.96. The company's market cap stands at…
benzinga.com Why Teladoc Stock is Getting Crushed Wednesday After Hours Teladoc stock is sinking Wednesday after the company reported Q2 results and updated guidance. Here are the key figures to know.- benzinga.com Teladoc Health Sees Q3 GAAP EPS $(0.30)-$(0.20) vs $(0.18) Est; Sees Sales $569.000M-$609.000M vs $629.252M Est Teladoc Health (NYSE:TDOC) is looking for Q3 GAAP EPS of $(0.30)-$(0.20) vs $(0.18) analyst estimate. sees sales of $569.000 million-$609.000 million vs $629.252 million analyst estimate.
benzinga.com Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.05)-$(0.75) to $(1.00)-$(0.75) vs $(0.92) Est; Lowers FY2026 Sales Guidance from $2.481B-$2.576B to $2.362B-$2.447B vs $2.508B Est Teladoc Health (NYSE:TDOC) raises FY2026 GAAP EPS guidance from $(1.05)-$(0.75) to $(1.00)-$(0.75) vs $(0.92) analyst estimate. Lowers FY2026 sales outlook from $2.481 billion-$2.576 billion to…- benzinga.com Teladoc Health Q2 EPS $(0.21) Beats $(0.25) Estimate, Sales $606.927M Miss $615.391M Estimate Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.25) by 16 percent. This is a 10.53 percent decrease over losses of $(0.19)…
- benzinga.com Teladoc Health Unveils Teladoc One, Predictive, Adaptive Model Of Virtual Care To Transform Outcomes And Lower Costs Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of careMultidisciplinary care teams, paired…
benzinga.com Synchrony Financial To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Wednesday Top analysts change outlook on top names. Baird, Canaccord Genuity, Needham, Stifel, Truist Securities raise price targets. See analyst ratings.
benzinga.com Robinhood To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday Wall Street analysts change outlook on top names. See all rating changes, including upgrades and downgrades, on analyst ratings page.- benzinga.com Canaccord Genuity Maintains Buy on Teladoc Health, Raises Price Target to $11 Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and raises the price target from $10 to $11.
benzinga.com Teladoc in the Spotlight as Investors Refocus on Company's Walmart Better Care Partnership Teladoc Health Inc. (NYSE: TDOC) shares are trending Wednesday as investors take a fresh look at the company.- benzinga.com Teledoc Unit BetterHelp Partners With The Institute Of Patient Safety And Quality Of Virtual Care Founded in 2019, The Institute of Patient Safety and Quality of Virtual Care is the first PSO dedicated to clinical quality and continuous improvement in virtual care.Federally recognized PSOs create…
benzinga.com Cathie Wood Bets On Kalshi, But Her Ark Innovation ETF Hasn't Been Great At Timing Winners Cathie Wood‘s ARK Invest joined Kalshi’s $1 billion Series F last week at a $22 billion valuation, slotting the prediction market behind only SpaceX and OpenAI in the ARK Venture Fund.- benzinga.com Citigroup Maintains Neutral on Teladoc Health, Raises Price Target to $7 Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and raises the price target from $6 to $7.
benzinga.com Teladoc Stock Slides Following Q1 Earnings Miss, Lower Guidance Teladoc Health Inc. shares are tumbling in Thursday's pre-market after mixed quarterly results and guidance signaling continued losses.
benzinga.com Meta, Ford, Willis Towers Watson And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures up, Nasdaq 100 gains 100 pts. Meta Platforms Inc shares dip 8.2% after Q1 results. Other stocks also lower in pre-market trading.
benzinga.com Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Other gainers include ABTS, AKAN, VSME, OSRH, AREB, VIAV, PI, INM, and MRAM.
benzinga.com Teladoc Shares Fall After Q1 Earnings: What Investors Need To know Teladoc stock is trading lower after reporting first-quarter financial results. Here are the highlights.- benzinga.com Teladoc Health Narrows FY2026 GAAP EPS Guidance from $(1.10)-$(0.70) to $(1.05)-$(0.75) vs $(0.89) Est; Narrows FY2026 Sales Guidance from $2.470B-$2.587B to $2.481B-$2.576B vs $2.509B Est. Teladoc Health (NYSE:TDOC) narrows FY2026 GAAP EPS guidance from $(1.10)-$(0.70) to $(1.05)-$(0.75) vs $(0.89) analyst estimate. Narrows FY2026 sales outlook from $2.470 billion-$2.587 billion to…
- benzinga.com Teladoc Health Sees Q2 GAAP EPS $(0.30)-$(0.20) vs $(0.23) Est; Sees Sales $597.000M-$626.000M vs $623.670M Est. Teladoc Health (NYSE:TDOC) is looking for Q2 GAAP EPS of $(0.30)-$(0.20) vs $(0.23) analyst estimate. sees sales of $597.000 million-$626.000 million vs $623.670 million analyst estimate.
- benzinga.com Teladoc Health Q1 EPS $(0.36) Misses $(0.33) Estimate, Sales $613.845M Beat $610.869M Estimate. Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 32.08 percent increase over losses of…